Correlation Between Ssangyong Materials and AptaBio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ssangyong Materials and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ssangyong Materials and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ssangyong Materials Corp and AptaBio Therapeutics, you can compare the effects of market volatilities on Ssangyong Materials and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ssangyong Materials with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ssangyong Materials and AptaBio Therapeutics.

Diversification Opportunities for Ssangyong Materials and AptaBio Therapeutics

-0.31

Correlation Coefficient

Ssangyong Materials  AptaBio Therapeutics

Very good diversification

The 3 months correlation between Ssangyong and AptaBio is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Ssangyong Materials Corp and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Ssangyong Materials is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ssangyong Materials Corp are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Ssangyong Materials i.e., Ssangyong Materials and AptaBio Therapeutics go up and down completely randomly.

Pair Corralation between Ssangyong Materials and AptaBio Therapeutics

Assuming the 90 days trading horizon Ssangyong Materials Corp is expected to generate 0.75 times more return on investment than AptaBio Therapeutics. However, Ssangyong Materials Corp is 1.34 times less risky than AptaBio Therapeutics. It trades about 0.07 of its potential returns per unit of risk. AptaBio Therapeutics is currently generating about -0.16 per unit of risk. If you would invest  218,500  in Ssangyong Materials Corp on September 3, 2024 and sell it today you would earn a total of  20,500  from holding Ssangyong Materials Corp or generate 9.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ssangyong Materials Corp  vs.  AptaBio Therapeutics

Ssangyong Materials Corp

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ssangyong Materials Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ssangyong Materials may actually be approaching a critical reversion point that can send shares even higher in January 2025.

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Ssangyong Materials and AptaBio Therapeutics

The main advantage of trading using opposite Ssangyong Materials and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ssangyong Materials position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.

The idea behind Ssangyong Materials Corp and AptaBio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..